Streetbeat News

Stock Prices

CPRT

The analysis of Copart (NASDAQ:CPRT) in the Commercial Services & Supplies industry reveals that the company may be overvalued based on its high PE, PB, and PS ratios compared to industry averages. Despite this, Copart shows strong profitability with higher EBITDA and gross profit. However, its ROE and revenue growth are below the industry average, indicating potential challenges in generating returns and expanding business. Copart's low debt-to-equity ratio suggests a strong financial position with less reliance on debt financing.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 4:00 pm

OXY

Occidental Petroleum (NYSE:OXY) has received 7 analyst ratings in the last quarter, with 1 bullish, 2 somewhat bullish, and 4 indifferent. There were no bearish or somewhat bearish ratings. The average price target is $72.57, suggesting an upside from the current price of $60.3. This target has increased by 0.23% over the past month. Analysts typically review stocks each quarter and provide ratings that reflect their outlook on stock performance.

Portfolio Pulse from Benzinga Insights

November 29, 2023 | 4:00 pm

VVOS

Trading in shares of Vivos Therapeutics, Inc. (VVOS) has resumed after being temporarily halted.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 3:58 pm

RDHL

Shares of Redhill Biopharma Ltd. (RDHL) were halted due to a circuit breaker after surging 43.9% to the upside.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 3:57 pm

AEIS

EAST

QBAK

XXII

22nd Century Group, Inc. (XXII) appoints Lawrence Firestone as chairman and CEO. The company also announced the sale of its GVB Biopharma operations to Specialty Acquisition Corporation for $2.25 million. Firestone has extensive experience, including roles as CEO of Eastside Distilling, Inc. (EAST) and Qualstar Corporation (QBAK), and CFO of Advanced Energy Industries (AEIS) and Applied Films Corporation (AFCO). 22nd Century reported an 8.2% drop in net revenue and a significant operating loss. The Blinc Group promoted Pete Sahani to CEO, with the former CEO taking a new role. XXII shares rose 10.6977% to $0.2380.

Portfolio Pulse from Jelena Martinovic

November 29, 2023 | 3:53 pm

VVOS

Shares of Vivos Therapeutics were halted due to a circuit breaker after experiencing a significant surge, with the stock price rising by 265.1%.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 3:53 pm

VVOS

Vivos Therapeutics shares have resumed trading after a temporary halt. The reason for the halt was not specified in the article.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 3:52 pm

WDAY

JMP Securities analyst Patrick Walravens has reiterated a 'Market Outperform' rating on Workday (NASDAQ:WDAY), maintaining a price target of $270.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 3:50 pm

SNOW

JMP Securities analyst Joe Goodwin has reiterated a 'Market Outperform' rating on Snowflake (NYSE:SNOW) and maintained a price target of $200. This reaffirmation of Snowflake's performance and target price suggests confidence in the company's future growth and market position.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 3:48 pm

VVOS

Shares of Vivos Therapeutics were halted due to a circuit breaker after surging 216.2% to the upside.

Portfolio Pulse from Benzinga Newsdesk

November 29, 2023 | 3:47 pm